| Name | oxolan-3-one |
|---|---|
| Synonyms |
tetrahydrofuran-4-one
g-Butyrolactone Dihydrofuran-3(2H)-one gama-Butyrolactone 3-Oxo-1,4-epoxybutane Dihydro-3(2H)-furanone tetrahydrofuran-3-one butyrolactone Dihydrofuran-3-one 2(3H)-Furanone, dihydro- 2,3,4,5-Tetrahydro-2-furanone 3-ketotetrahydrofuran tetrahydrofuran-2-one 3(2H)-Furanone, dihydro- Dihydrofuran-2(3H)-one 1-Oxacyclopentan-2-one 3-Oxotetrahydrofuran 2-OXOTETRAHYDROFURAN Dihydro-2(3H)-furanone g-Hydroxybutyric Acid Lactone 3(2H)-Furanone, dihydro 4,5-Dihydro-2(3H)-furanone γ-Butyrolactone 1-Oxacyclopentane-2-one Tetrahydrofuran-3-yloxy γ-Hydroxybutyric acid lactone Dihydrofuran-3(2H)-on |
| Description | Dihydrofuran-3(2H)-one (3-Oxotetrahydrofuran) is used for synthesizing cyclic ketone inhibitors that inhibits the serine protease plasmin[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 151.1±23.0 °C at 760 mmHg |
| Molecular Formula | C4H6O2 |
| Molecular Weight | 86.089 |
| Flash Point | 56.3±16.2 °C |
| Exact Mass | 86.036781 |
| PSA | 26.30000 |
| LogP | -1.14 |
| Vapour Pressure | 3.7±0.3 mmHg at 25°C |
| Index of Refraction | 1.442 |
| Hazard Codes | Xn:Harmful; |
|---|---|
| Risk Phrases | R22;R36/37/38 |
| Safety Phrases | S23-S26-S36/37/39 |
| RIDADR | UN 1993 |
| HS Code | 2932190090 |
| Precursor 4 | |
|---|---|
| DownStream 4 | |
| HS Code | 2932190090 |
|---|---|
| Summary | 2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |